Clinical Significance of Sphingosine-1-Phosphate in the Evaluation of Endothelial Function and Cardiovascular Risk in Hypertension.
Phase of Trial: Phase II
Latest Information Update: 12 May 2016
At a glance
- Drugs Atenolol (Primary) ; Telmisartan (Primary)
- Indications Hypertension
- Focus Pharmacodynamics
- Acronyms SEE-THRU BP
- 06 Apr 2011 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
- 15 Mar 2011 New trial record